Get the tools used by (smart)2 investors.

Debt / Common Equity for Assertio Therapeutics Inc

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

ASRT: Assertio Therapeutics Inc

Assertio Holdings, Inc., a pharmaceutical company, provides various products to patients in the United States. Its pharmaceutical products include INDOCIN, an oral and suppository solution for the tre...

- USD
Price
USD
Fair Value
Upside
- - -
52-week range

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Assertio Therapeutics Inc's Debt / Common Equity:

Dec 2016Dec 2018Dec 2020Dec 2022Dec 2024200.0%400.0%600.0%

Performance Summary
  • Assertio Therapeutics's debt / equity last quarter was 33.3%
  • Assertio Therapeutics's debt / equity for fiscal years ending December 2020 to 2024 averaged 65.6%.
  • Assertio Therapeutics's operated at median debt / equity of 33.3% from fiscal years ending December 2020 to 2024.
  • Looking back at the last 5 years, Assertio Therapeutics's debt / equity peaked in December 2020 at 161.4%.
  • Assertio Therapeutics's debt / equity hit its 5-year low in December 2023 of 29.6%.
  • Assertio Therapeutics's debt / equity decreased in 2020 (161.4%, -73.9%), 2021 (74.1%, -54.1%), 2022 (29.8%, -59.8%), and 2023 (29.6%, -0.5%) and increased in 2024 (33.3%, +12.2%).

Benchmarks

Metric Usage: Debt / Equity

Hide this widget
debt_to_equity
Slug
number
Datatype
text
Format
current
Default Period
FY, Q
Periods Supported
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Search for metric or datapoint

Debt / Equity

A ratio that measures the level of the debt relative to the book value of common equity.

Definition of Debt / Common Equity

Hide this widget

Debt / Equity is defined as:

Total Debt
(/) Total Common Equity
(=) Debt / Equity

Debt / Equity for Assertio is calculated as follows:

Total Debt [ 40.266 M]
(/) Total Common Equity [ 121.1 M ]
(=) Debt / Equity [ 33.3% ]

The tables below summarizes the trend in Assertio’s Debt / Equity over the last five years:

Fiscal Year Total Debt Total Common Equity Debt / Equity
2020-12-31 89.6 M 55.514 M 161.4%
2021-12-31 75.868 M 102.4 M 74.1%
2022-12-31 67.274 M 225.7 M 29.8%
2023-12-31 40.912 M 138 M 29.6%
2024-12-31 40.266 M 121.1 M 33.3%

The tables below summarizes the trend in Assertio’s Debt / Equity over the last four quarters:

Fiscal Quarter Total Debt Total Common Equity Debt / Equity
2024-03-31 40.768 M 134.5 M 30.3%
2024-06-30 40.648 M 132.2 M 30.8%
2024-09-30 40.527 M 130.5 M 31.1%
2024-12-31 40.266 M 121.1 M 33.3%

The higher the ratio, the more debt the company has in its capital structure.

Read More on HBR: Debt / Equity Ratio


Click the link below to download a spreadsheet with an example Debt / Common Equity calculation for Assertio Therapeutics Inc below:

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
-328.7%-28.7%271.3%599.4%2006001,000

The chart above depicts the distribution of debt / common equity for companies operating in the Healthcare sector in the Developed economic region. Over 2,430 companies were considered in this analysis, and 2,341 had meaningful values. The average debt / common equity of companies in the sector is 27.9% with a standard deviation of 99.2%.

Assertio Therapeutics Inc's Debt / Common Equity of 33.3% ranks in the 69.6% percentile for the sector. The following table provides additional summary stats:

Debt / Common Equity In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents2,439
Included Constituents2,341
Min-332.6%
Max580.5%
Median7.5%
Mean27.9%
Standard Deviation99.2%

You can find companies with similar debt / common equity using this stock screener.

All rights reserved. Terms Of Use